{"id":6418,"date":"2023-12-21T20:04:49","date_gmt":"2023-12-21T14:34:49","guid":{"rendered":"https:\/\/pharmaceuticalcarrier.com\/?p=6418"},"modified":"2023-12-23T11:37:06","modified_gmt":"2023-12-23T06:07:06","slug":"mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence","status":"publish","type":"post","link":"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/","title":{"rendered":"&#8220;Mastering Photostability: A Deep Dive into ICH Guidelines Q1B for Pharmaceutical Excellence&#8221;"},"content":{"rendered":"\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_76 counter-hierarchy ez-toc-counter ez-toc-transparent ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title\" style=\"cursor:inherit\">Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Introduction\" >Introduction:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Background\" >Background:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Scope_and_Applicability\" >Scope and Applicability:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Key_Elements_of_ICH_Guidelines_Q1B\" >Key Elements of ICH Guidelines Q1B:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Practical_Implications\" >Practical Implications:<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Frequently_Asked_Questions\" >Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#1_What_is_the_primary_focus_of_ICH_Guidelines_Q1B\" >1. What is the primary focus of ICH Guidelines Q1B?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#2_Why_is_photostability_testing_important\" >2. Why is photostability testing important?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#3_What_types_of_products_do_ICH_Guidelines_Q1B_apply_to\" >3. What types of products do ICH Guidelines Q1B apply to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#4_What_are_the_key_elements_of_ICH_Guidelines_Q1B\" >4. What are the key elements of ICH Guidelines Q1B?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#5_How_does_Q1B_address_light_sources_and_conditions\" >5. How does Q1B address light sources and conditions?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#6_What_is_the_significance_of_sample_presentation_in_photostability_testing\" >6. What is the significance of sample presentation in photostability testing?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#7_How_does_Q1B_address_the_duration_of_exposure_during_testing\" >7. How does Q1B address the duration of exposure during testing?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#8_Why_is_monitoring_and_evaluation_emphasized_in_Q1B\" >8. Why is monitoring and evaluation emphasized in Q1B?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#9_What_are_the_practical_implications_of_implementing_Q1B_for_pharmaceutical_companies\" >9. What are the practical implications of implementing Q1B for pharmaceutical companies?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#10_How_do_ICH_Guidelines_Q1B_contribute_to_global_harmonization_in_the_pharmaceutical_industry\" >10. How do ICH Guidelines Q1B contribute to global harmonization in the pharmaceutical industry?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/2023\/12\/21\/mastering-photostability-a-deep-dive-into-ich-guidelines-q1b-for-pharmaceutical-excellence\/#Conclusion\" >Conclusion:<\/a><\/li><\/ul><\/nav><\/div>\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Introduction\"><\/span><em>Introduction:<\/em> <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) plays a pivotal role in promoting global harmonization in the development and registration of pharmaceutical products. Among the various guidelines provided by ICH, Q1B specifically addresses the photostability testing of new drug substances and products. Let&#8217;s delve into the key aspects of ICH Guidelines Q1B.<\/p><div class=\"pharm-content\" id=\"pharm-24713502\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-8402705006112223\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-8402705006112223\" \ndata-ad-slot=\"7652789694\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Background\"><\/span><em>Background:<\/em> <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>ICH Guidelines Q1B originated from the need for standardized testing procedures to evaluate the impact of light on pharmaceutical products. Light exposure can lead to chemical and physical changes in drugs, affecting their stability and efficacy. The guidelines were developed collaboratively by regulatory authorities and industry experts to ensure consistency in photostability testing methodologies.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Scope_and_Applicability\"><\/span><em>Scope and Applicability:<\/em> <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p>The primary scope of Q1B is to provide guidance on the design of photostability testing for new drug substances and associated products. It applies to both synthetic and biotechnologically derived products. Understanding the photostability characteristics of a drug is crucial for determining appropriate packaging and storage conditions, ultimately ensuring product quality.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Key_Elements_of_ICH_Guidelines_Q1B\"><\/span><em>Key Elements of ICH Guidelines Q1B:<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<ol class=\"wp-block-list\">\n<li><strong>Light Sources and Conditions:<\/strong>\n<ul class=\"wp-block-list\">\n<li>The guidelines specify the types of light sources suitable for testing, considering the spectral distribution and intensity.<\/li>\n\n\n\n<li>Conditions, including temperature and humidity, are outlined to mimic real-world scenarios and ensure realistic assessments.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Sample Presentation:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Q1B provides recommendations on sample presentation, emphasizing the importance of exposing all parts of the product to light adequately.<\/li>\n\n\n\n<li>This includes considerations for liquid and solid dosage forms.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Testing Duration:<\/strong>\n<ul class=\"wp-block-list\">\n<li>The duration of exposure is a critical factor. Q1B defines appropriate timeframes for testing, considering the intended conditions of drug product use.<\/li>\n<\/ul>\n<\/li>\n\n\n\n<li><strong>Monitoring and Evaluation:<\/strong>\n<ul class=\"wp-block-list\">\n<li>Regular monitoring of the samples during exposure is emphasized, and evaluation criteria are provided to assess any observed changes.<\/li>\n\n\n\n<li>Acceptance criteria help in determining the impact of light exposure on product quality.<\/li>\n<\/ul>\n<\/li>\n<\/ol>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Practical_Implications\"><\/span><em>Practical Implications:<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p> Implementation of ICH Guidelines Q1B has practical implications for pharmaceutical companies. By adhering to these guidelines, companies can:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ensure regulatory compliance and facilitate the global acceptance of their products.<\/li>\n\n\n\n<li>Optimize packaging design to protect drug products from light-induced degradation.<\/li>\n\n\n\n<li>Enhance the overall quality and stability of pharmaceutical products.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span>Frequently Asked Questions <span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"1_What_is_the_primary_focus_of_ICH_Guidelines_Q1B\"><\/span><strong>1. What is the primary focus of ICH Guidelines Q1B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>ICH Guidelines Q1B primarily focus on providing guidance for the photostability testing of new drug substances and products. The goal is to assess the impact of light exposure on pharmaceuticals to ensure their stability and efficacy.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"2_Why_is_photostability_testing_important\"><\/span><strong>2. Why is photostability testing important?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Photostability testing is crucial to understand how light exposure can affect the stability of drug substances and products. It helps in determining appropriate packaging, storage conditions, and ensuring product quality.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"3_What_types_of_products_do_ICH_Guidelines_Q1B_apply_to\"><\/span><strong>3. What types of products do ICH Guidelines Q1B apply to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Q1B applies to both synthetic and biotechnologically derived drug substances and products. It encompasses a wide range of pharmaceuticals to ensure comprehensive testing standards.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"4_What_are_the_key_elements_of_ICH_Guidelines_Q1B\"><\/span><strong>4. What are the key elements of ICH Guidelines Q1B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The guidelines cover aspects such as the types of light sources and conditions for testing, sample presentation recommendations, testing duration, and monitoring and evaluation criteria to assess changes induced by light exposure.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"5_How_does_Q1B_address_light_sources_and_conditions\"><\/span><strong>5. How does Q1B address light sources and conditions?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Q1B specifies suitable light sources based on their spectral distribution and intensity. It also outlines conditions, including temperature and humidity, to replicate real-world scenarios during testing.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"6_What_is_the_significance_of_sample_presentation_in_photostability_testing\"><\/span><strong>6. What is the significance of sample presentation in photostability testing?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Sample presentation is crucial to ensure that all parts of the drug product are adequately exposed to light. The guidelines provide recommendations for presenting both liquid and solid dosage forms during testing.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"7_How_does_Q1B_address_the_duration_of_exposure_during_testing\"><\/span><strong>7. How does Q1B address the duration of exposure during testing?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>The guidelines define appropriate timeframes for light exposure, taking into account the intended conditions of drug product use. This helps in determining the impact of light exposure on product stability.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"8_Why_is_monitoring_and_evaluation_emphasized_in_Q1B\"><\/span><strong>8. Why is monitoring and evaluation emphasized in Q1B?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Regular monitoring during exposure and thorough evaluation of observed changes are essential to assess the impact of light on the product. Acceptance criteria are provided to determine the product&#8217;s photostability.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"9_What_are_the_practical_implications_of_implementing_Q1B_for_pharmaceutical_companies\"><\/span><strong>9. What are the practical implications of implementing Q1B for pharmaceutical companies?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Implementation of Q1B ensures regulatory compliance, facilitates global acceptance of products, optimizes packaging design, and enhances overall product quality and stability.<\/li>\n<\/ul>\n\n\n\n<h3 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"10_How_do_ICH_Guidelines_Q1B_contribute_to_global_harmonization_in_the_pharmaceutical_industry\"><\/span><strong>10. How do ICH Guidelines Q1B contribute to global harmonization in the pharmaceutical industry?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n\n\n\n<ul class=\"wp-block-list\">\n<li>By providing standardized testing procedures, Q1B promotes global harmonization in the development and registration of pharmaceutical products. This consistency ensures that products meet quality standards accepted worldwide.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\"><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><em>Conclusion:<\/em><span class=\"ez-toc-section-end\"><\/span><\/h2>\n\n\n\n<p> In conclusion, ICH Guidelines Q1B stand as a crucial framework for assessing the photostability of new drug substances and products. By following these guidelines, the pharmaceutical industry can uphold quality standards, promote global harmonization, and ultimately contribute to the delivery of safe and effective medications worldwide.<\/p>\n\n\n\n<p>For more articles,&nbsp;<strong><a href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/ayurveda\/\">Kindly Click<\/a>&nbsp;here<\/strong>.<\/p>\n\n\n\n<p>For pharmaceutical jobs, follow us on<strong>&nbsp;<a href=\"https:\/\/www.linkedin.com\/company\/pharmaceuticalcarrier\/?viewAsMember=true\" target=\"_blank\" rel=\"noreferrer noopener\">LinkedIn<\/a><\/strong><\/p>\n\n\n\n<p><strong>For more jobs, kindly visit our job section.<\/strong><a href=\"https:\/\/pharmaceuticalcarrier.com\/index.php\/jobs\/\">www.pharmaceuticalcarrier.com\/Jobs<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>&#8220;Explore ICH Guidelines Q1B for Photostability Testing in pharmaceuticals. Learn about regulatory compliance, packaging design, and global harmonization. Understand the key elements: light exposure, testing duration, and sample presentation. Ensure stability and quality in drug substances and products.&#8221;<\/p>\n","protected":false},"author":1,"featured_media":6404,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_uag_custom_page_level_css":"","footnotes":""},"categories":[1016],"tags":[726,1173,1180,1176,1163,1178,1170,1168,1169,1174,157,1167,1175,348,1172,1177,826,1179,1171],"class_list":["post-6418","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ich-guidelines","tag-acceptance-criteria","tag-biotechnologically-derived-products","tag-dosage-forms","tag-drug-substances","tag-global-harmonization","tag-humidity","tag-ich-guidelines-q1b","tag-light-exposure","tag-monitoring-and-evaluation","tag-packaging-design","tag-pharmaceutical-industry","tag-pharmaceutical-products","tag-photostability-testing","tag-regulatory-compliance","tag-sample-presentation","tag-spectral-distribution","tag-stability-assessment","tag-temperature","tag-testing-duration"],"uagb_featured_image_src":{"full":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"thumbnail":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3-150x150.jpg",150,150,true],"medium":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"medium_large":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"large":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"1536x1536":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"2048x2048":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false],"authorship-box-avatar":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3-150x150.jpg",150,150,true],"authorship-box-related":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3-70x70.jpg",70,70,true],"sow-carousel-default":["https:\/\/pharmaceuticalcarrier.com\/wp-content\/uploads\/2023\/12\/images-3.jpg",214,178,false]},"uagb_author_info":{"display_name":"Pharmacareer","author_link":"https:\/\/pharmaceuticalcarrier.com\/index.php\/author\/grandirpharmagmail-com\/"},"uagb_comment_info":2,"uagb_excerpt":"\"Explore ICH Guidelines Q1B for Photostability Testing in pharmaceuticals. Learn about regulatory compliance, packaging design, and global harmonization. Understand the key elements: light exposure, testing duration, and sample presentation. Ensure stability and quality in drug substances and products.\"","amp_enabled":true,"_links":{"self":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/posts\/6418","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/comments?post=6418"}],"version-history":[{"count":2,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/posts\/6418\/revisions"}],"predecessor-version":[{"id":6429,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/posts\/6418\/revisions\/6429"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/media\/6404"}],"wp:attachment":[{"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/media?parent=6418"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/categories?post=6418"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharmaceuticalcarrier.com\/index.php\/wp-json\/wp\/v2\/tags?post=6418"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}